
News
News
13 October 2020
Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy
23 September 2020
04 September 2019
28 March 2019
29 December 2018
1
2
13 October 2020
Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy
23 September 2020
04 September 2019
28 March 2019
29 December 2018